211 related articles for article (PubMed ID: 9838562)
1. Monitoring of anti-rejection therapy by serum bile acids after liver transplantation.
Klar E; Theilmann L; Hoffmann V; Hofmann W; Kraus T; Mehrabi A; Herfarth C
Transplant Proc; 1998 Nov; 30(7):3567-9. PubMed ID: 9838562
[No Abstract] [Full Text] [Related]
2. Strategy for chronic rejection in recipient of living-related liver transplantation.
Koyamada N; Ohkohchi N; Doi H; Orii T; Kikuchi H; Chubachi S; Sekiguchi S; Kawagishi N; Haga I; Nakajima N; Satomi S; Oguma S
Transplant Proc; 2000 Nov; 32(7):2134-6. PubMed ID: 11120102
[No Abstract] [Full Text] [Related]
3. Steroid withdrawal is safe and beneficial in stable cyclosporine-treated liver transplant patients.
Gómez R; Moreno E; Colina F; Loinaz C; Gonzalez-Pinto I; Lumbreras C; Perez-Cerdá F; Castellón C; García I
J Hepatol; 1998 Jan; 28(1):150-6. PubMed ID: 9537852
[TBL] [Abstract][Full Text] [Related]
4. Trough level-guided mycophenolate mofetil rejection prophylaxis in liver transplantation.
Grasser B; Iberer F; Schaffellner S; Kniepeiss D; Stauber R; Koshsorur G; Rehak P; Tscheliessnigg KH
Transplant Proc; 2001 May; 33(3):2154-6. PubMed ID: 11377484
[No Abstract] [Full Text] [Related]
5. High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study.
Cherqui D; Duvoux C; Salvat A; Lauzet JY; Metreau JM; Julien M; Fagniez PL; Dhumeaux D
Transplant Proc; 1995 Feb; 27(1):1134-5. PubMed ID: 7878824
[No Abstract] [Full Text] [Related]
6. Cyclosporine A monitoring in liver transplant.
Tisone G; Vennarecci G; Pisani F; Pieragostini E; Alciati E; Casciani CU
Transplant Proc; 1994 Oct; 26(5):2691-2. PubMed ID: 7940842
[No Abstract] [Full Text] [Related]
7. Intensive care after orthotopic liver transplantation.
Sun CK; Chen CL; Kuo YC; Chen YS
Transplant Proc; 1994 Aug; 26(4):2246-7. PubMed ID: 7520627
[No Abstract] [Full Text] [Related]
8. Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
Woodle ES; So S; Jendrisak MD; Perdrizet GA; White HM; Marsh JW
Transplant Proc; 1993 Apr; 25(2):1988-9. PubMed ID: 7682358
[No Abstract] [Full Text] [Related]
9. Transient hyperphosphatasemia after liver transplantation in infancy.
Lachaux A; Chambon M; Boillot O; Le Gall C; Loras I; Canterino I; Pouillaude JM; Gille D; David L; Hermier M
Transplant Proc; 1996 Oct; 28(5):2847. PubMed ID: 8908095
[No Abstract] [Full Text] [Related]
10. Induction therapy with anti-T-lymphocyte globulin following orthotopic liver transplantation.
Schattenfroh N; Lange D; Bechstein WO; Blumhardt G; Keck H; Langrehr JM; Lohmann R; Neuhaus P
Transplant Proc; 1993 Aug; 25(4):2702. PubMed ID: 8356722
[No Abstract] [Full Text] [Related]
11. Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection.
Wiesner RH; Porayko MK; Wahlstrom HE; Gores GJ; Kamath PS; Hay JE; Krom RA
Transplant Proc; 1993 Apr; 25(2):1791-3. PubMed ID: 7682352
[No Abstract] [Full Text] [Related]
12. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
Reggiani P; Rossi G; Latham L; Caccamo L; Gatti S; Maggi U; Melada E; Paone G; Doglia M; Vannelli A; Fassati LR
Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308
[No Abstract] [Full Text] [Related]
13. Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral.
Levy GA
Transplant Proc; 1996 Aug; 28(4):2252-3. PubMed ID: 8769216
[No Abstract] [Full Text] [Related]
14. Influence of the anti-CD25 monoclonal antibody BT563 on clinical and biological rejection after orthotopic liver transplantation.
Otto G; Hofmann WJ; Gaweco AS; Seelos R; Herfarth C; Meuer S
Transplant Proc; 1996 Dec; 28(6):3210-1. PubMed ID: 8962244
[No Abstract] [Full Text] [Related]
15. Ex vivo perfusion of livers with anti-class II antibody and acute rejection in canine liver transplantation.
Sakagami K; Saito S; Kurozumi Y; Kobayashi N; Fujiwara T; Matsuno T; Orita K
Transplant Proc; 1993 Apr; 25(2):1959-61. PubMed ID: 8470243
[No Abstract] [Full Text] [Related]
16. Metabolic findings after liver transplantation within a randomised trial with or without steroids.
Tisone G; Angelico M; Vennarecci G; Palmieri G; Buonomo O; Negrini S; Casciani CU
Transplant Proc; 1998 Jun; 30(4):1447-8. PubMed ID: 9636587
[No Abstract] [Full Text] [Related]
17. Immunobiology of hepatic nonparenchymal cells and ex vivo perfusion of the livers with anti-class II antibody: a strategy to prevent hepatic rejection in the dog.
Sakagami K; Kurozumi Y; Tanakaya K; Saito S; Fujiwara T; Inagaki M; Matsuno T; Takasu S; Higaki K; Toda K
Transplant Proc; 1995 Feb; 27(1):533-6. PubMed ID: 7879090
[No Abstract] [Full Text] [Related]
18. Low incidence of acute cellular rejection in liver transplantation with Neoral.
Imventarza O; Lendoire J; Bianco G; Saúl J; Braslavsky G; Trigo P; Cueto G; Duek F; Aziz H
Transplant Proc; 1998 Aug; 30(5):1854. PubMed ID: 9723307
[No Abstract] [Full Text] [Related]
19. Evaluation of hepatic excretory system function by determination of serum bile acid clearance early after liver transplantation.
Kohlhaw K; Canello R; Ringe B; Hauss J; Schumann G; Oellerich M; Pichlmayr R
Transplant Proc; 1992 Dec; 24(6):2699-700. PubMed ID: 1465905
[No Abstract] [Full Text] [Related]
20. Successful conversion from cyclosporine to tacrolimus for immunosuppression.
Sekido H; Takeda K; Morioka D; Kubota T; Togo S; Nakatani Y; Matsunami H; Lynch SV; Strong RW; Shimada H
Transplant Proc; 2000 Nov; 32(7):2120-2. PubMed ID: 11120096
[No Abstract] [Full Text] [Related]
[Next] [New Search]
